Author

Klaudyna Fidyt

Instituto de Salud Carlos IIIORCID 0000-0003-0568-4950Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Narcís Fernández‐FuentesiD· 2 shared Pablo R. MenéndeziD· 2 shared Adela EscuderoiD· 1 shared Agnieszka Graczyk‐JarzynkaiD· 1 shared Aïda FalgàsiD· 1 shared Alba Garcia-Perez· 1 shared Alba Martínez‐Moreno· 1 shared André BarucheliD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Narcís Fernández‐FuentesORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologyJournal of Hematology & OncologyPeer-reviewedJul 1, 2025

CAR-T cells targeting CCR9 and CD1a for the treatment of T cell acute lymphoblastic leukemia

Néstor Tirado, Klaudyna Fidyt, María José Mansilla…·Pablo R. Menéndez

This paper develops and validates a dual-targeting CAR-T cell therapy for T-ALL that targets CCR9 and CD1a, showing improved efficacy and safety compared to single-targeting approaches.

13 citationstop 4%

humanexperimental assay

𝕏 PostBluesky

ImmunologybioRxivPreprintFeb 28, 2025

The costimulatory domain influences CD19 CAR-T cell resistance development in B-cell malignancies.

Marta Krawczyk, Narcís Fernández‐Fuentes, Klaudyna Fidyt…·Magdalena Winiarska

This study identifies that the costimulatory domain of CD19-CAR-T cells influences resistance development in B-cell malignancies by affecting CD19 loss and antigen escape.

5 citations

humanexperimental assay

𝕏 PostBluesky